U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 761354
Company: BIOGEN MA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TOFIDENCE TOCILIZUMAB-BAVI 80MG/4ML INJECTABLE;INJECTION Prescription None No No
TOFIDENCE TOCILIZUMAB-BAVI 200MG/10ML INJECTABLE;INJECTION Prescription None No No
TOFIDENCE TOCILIZUMAB-BAVI 400MG/20ML INJECTABLE;INJECTION Prescription None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/29/2023 ORIG-1 Approval N/A Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761354s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761354Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/761354Orig1s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/03/2024 SUPPL-4 Supplement Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761354Orig1s004ltr.pdf
07/22/2024 SUPPL-2 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761354Orig1s002ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
07/22/2024 SUPPL-2 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s002lbl.pdf
07/22/2024 SUPPL-2 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s002lbl.pdf
07/22/2024 SUPPL-2 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s002lbl.pdf
09/29/2023 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761354s000lbl.pdf
Back to Top